K M K Bottomley
- Cancer Research top 5%
- Oncology top 10%
- Molecular Biology
- Rheumatology top 5%
- Hematology top 10%
- Co-authors
- Maria G. BelvisiWilliam H. JohnsonJohn NixonD. BradshawMichael BrewsterKevin L. WilsonMichael J. BroadhurstPaul A. Brown
- Topics
- Protease and Inhibitor Mechanisms (10 papers)Osteoarthritis Treatment and Mechanisms (5 papers)Blood Coagulation and Thrombosis Mechanisms (4 papers)
- Partner nations
- United KingdomUnited StatesSwitzerland
In The Last Decade
K M K Bottomley
19 papers receiving 649 citations
Peers
Comparison fields: 5 of 83
- Cancer Research 370
- Oncology 244
- Molecular Biology 185
- Rheumatology 182
- Hematology 119
Countries citing papers authored by K M K Bottomley
This map shows the geographic impact of K M K Bottomley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K M K Bottomley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K M K Bottomley more than expected).
Fields of papers citing papers by K M K Bottomley
This network shows the impact of papers produced by K M K Bottomley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K M K Bottomley. The network helps show where K M K Bottomley may publish in the future.
Co-authorship network of co-authors of K M K Bottomley
This figure shows the co-authorship network connecting the top 25 collaborators of K M K Bottomley. A scholar is included among the top collaborators of K M K Bottomley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K M K Bottomley. K M K Bottomley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 135 | |
| 2 | 30 | |
| 3 | 38 | |
| 4 | 82 | |
| 5 | 66 | |
| 6 | Targets for Drug Design | 1 |
| 7 | 100 | |
| 8 | 32 | |
| 9 | 31 | |
| 10 | 83 | |
| 11 | Potent collagenase inhibitors prevent interleukin-1-induced cartilage degradation in vitro. | 41 |
| 12 | 30 | |
| 13 | 1 | |
| 14 | 1 | |
| 15 | 2 | |
| 16 | 3 | |
| 17 | 2 | |
| 18 | 5 | |
| 19 | 6 |
About K M K Bottomley
K M K Bottomley is a scholar working on Cancer Research, Rheumatology and Immunology and Allergy, having authored 19 papers that have together received 689 indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (10 papers), Osteoarthritis Treatment and Mechanisms (5 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). The work is most often cited by research in Cancer Research (370 citations), Rheumatology (182 citations) and Hematology (119 citations). K M K Bottomley has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include Maria G. Belvisi, William H. Johnson, John Nixon, D. Bradshaw, Michael Brewster, Kevin L. Wilson, Michael J. Broadhurst, Paul A. Brown, Andrew Docherty and P Hill. Their work appears in journals such as Biochemical Journal, British Journal of Pharmacology and Journal of Pharmacy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.